Published in Ann Thorac Surg on October 01, 1999
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care (2010) 1.10
Improving outcomes in patients with ventricular assist devices transferred from outlying to tertiary care hospitals. J Extra Corpor Technol (2007) 0.79
Ventricular assist device therapy in post-cardiotomy cardiogenic shock: historical outcomes and current trends. Interact Cardiovasc Thorac Surg (2012) 0.76
Mechanical circulatory support with the ABIOMED BVS 5000: the Toronto General Hospital experience. Can J Cardiol (2010) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell (1990) 8.30
Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation (1997) 4.61
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg (2001) 2.80
Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother (1999) 2.54
Plant canopy gap-size analysis theory for improving optical measurements of leaf-area index. Appl Opt (1995) 2.42
LAI inversion algorithm based on directional reflectance kernels. J Environ Manage (2006) 2.31
Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29
Regional patterns of soil organic carbon stocks in China. J Environ Manage (2006) 2.21
Implantable left ventricular assist devices. N Engl J Med (1998) 2.07
Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg (1997) 2.01
Human herpesvirus-6 associated with fatal haemophagocytic syndrome. Lancet (1990) 1.99
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Spatial scaling between leaf area index maps of different resolutions. J Environ Manage (2006) 1.93
Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg (1992) 1.88
Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol (2001) 1.84
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest (1996) 1.81
A regional survey of health insurance coverage for complementary and alternative medicine: current status and future ramifications. J Altern Complement Med (2001) 1.77
Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med (2000) 1.76
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood (1995) 1.73
The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB. J Bacteriol (1999) 1.71
Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg (2001) 1.68
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Cerebrospinal fluid leak after acoustic neuroma surgery: influence of tumor size and surgical approach on incidence and response to treatment. J Neurosurg (2001) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent. Thromb Haemost (1996) 1.63
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg (1995) 1.56
Local degradation of fibronectin at sites of expression of the transforming gene product pp60src. Nature (1985) 1.55
Cerebral blood flow is determined by arterial pressure and not cardiopulmonary bypass flow rate. Ann Thorac Surg (1995) 1.55
Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation (1995) 1.49
Conformation-dependent phosphorylation of p53. Proc Natl Acad Sci U S A (1997) 1.49
The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49
Preservation of anterior leaflet chordae tendineae during mitral valve replacement. Ann Thorac Surg (1994) 1.47
Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg (1997) 1.47
Net primary productivity of China's terrestrial ecosystems from a process model driven by remote sensing. J Environ Manage (2007) 1.43
Exposure of the intramyocardial left anterior descending artery. Ann Thorac Surg (1994) 1.43
Optimization of long-distance PCR using a transposon-based model system. PCR Methods Appl (1992) 1.42
Surgical management of cardiac pheochromocytoma. Resection versus transplantation. Ann Surg (1995) 1.42
Pediatric cardiac transplantation using hearts previously refused for quality: a single center experience. Am J Transplant (2013) 1.41
Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg (1994) 1.40
Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med (2000) 1.40
Sigma factors of Mycobacterium tuberculosis. Tuber Lung Dis (1997) 1.40
Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg (1998) 1.39
Discrepancy between claimed field flux density of some commercially available magnets and actual gaussmeter measurements. Altern Ther Health Med (2001) 1.39
Retrograde cardioplegia preserves myocardial function after induced coronary air embolism. J Thorac Cardiovasc Surg (1997) 1.38
An integrated assessment model of carbon sequestration benefits: a case study of Liping county, China. J Environ Manage (2006) 1.38
Combining remote sensing imagery and forest age inventory for biomass mapping. J Environ Manage (2006) 1.37
Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995. J Thorac Cardiovasc Surg (1999) 1.34
Prophylactic photopheresis and effect on graft atherosclerosis in cardiac transplantation. Transplant Proc (1995) 1.32
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation (2000) 1.32
Conditional sigma factor expression, using the inducible acetamidase promoter, reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 16-kilodalton alpha-crystallin homologue. J Bacteriol (1999) 1.32
Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest (1998) 1.30
Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors. J Mol Biol (2008) 1.30
Application of a new leaf area index algorithm to China's landmass using MODIS data for carbon cycle research. J Environ Manage (2006) 1.29
Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg (1999) 1.28
Experience with heart transplantation for cardiac tumors. J Heart Lung Transplant (1995) 1.28
Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet (2000) 1.27
Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med (1997) 1.24
Coupled expression and colocalization of 140K cell adhesion molecules, fibronectin, and laminin during morphogenesis and cytodifferentiation of chick lung cells. J Cell Biol (1986) 1.23
Two novel severe mutations in the pancreatic secretory trypsin inhibitor gene (SPINK1) cause familial and/or hereditary pancreatitis. Hum Mutat (2004) 1.23
Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation (1993) 1.22
Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation (2000) 1.21
Novel technique to repair type A acute aortic dissection in patients with a left ventricular assist device. Ann Thorac Surg (2001) 1.21
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation (1997) 1.20
Autologous fibrin glue from intraoperatively collected platelet-rich plasma. Ann Thorac Surg (1992) 1.18
Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation (1995) 1.16
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16